PHVS filings show insider 10b5-1 sales in 2026

PHVS reports insider sales under pre-arranged 10b5-1 plans by Anne Simonne J. Lesage and Graymatters Consulting B.V.

Rhea-AI Filing Summary

PHVS reports insider sales under pre-arranged 10b5-1 plans by Anne Simonne J. Lesage and Graymatters Consulting B.V. The excerpt lists multiple completed 10b5-1 sales of Common stock on specific dates in 2026, including 21,700 shares on 04/30/2026 and 8,300 shares on 06/29/2026 by the named parties.

The filing records each sale with the trade date and gross proceeds shown in dollars; cash-flow treatment and aggregate registered offering details are not included in the provided excerpt.

Insights

Corporate Governance Specialist

Multiple scheduled 10b5-1 dispositions by an individual and an affiliated entity are documented.

The excerpt lists sequential 10b5-1 sales by Anne Simonne J. Lesage and Graymatters Consulting B.V. with specific trade dates and gross proceeds, indicating sales were executed under pre-arranged plans rather than ad-hoc open-market timing.

These entries show realized liquidity events tied to defined sale programs; subsequent filings would clarify total registered amounts and whether further planned dispositions remain.

Key Figures

Sale example: 21,700 shares Gross proceeds example: $656,550.86 Sale example: 8,300 shares +3 more

6 metrics

Sale example 21,700 shares 04/30/2026 sale by Anne Simonne J. Lesage

Gross proceeds example $656,550.86 Proceeds for 21,700-share sale on 04/30/2026

Sale example 8,300 shares 06/29/2026 sale by Anne Simonne J. Lesage

Gross proceeds example $290,907.83 Proceeds for 8,300-share sale on 06/29/2026

Sale example 19,200 shares 04/30/2026 sale by Graymatters Consulting B.V.

Gross proceeds example $580,909.44 Proceeds for 19,200-share sale on 04/30/2026

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for ANNE SIMONNE J. LESAGE"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares financial

"Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

What does the PHVS Form 144 excerpt show about insider activity?

It shows multiple 10b5-1 sales of PHVS Common stock by Anne Lesage and Graymatters Consulting B.V. on dated trades in 2026, each with shares and gross dollar amounts listed for each sale.

Who executed the sales reported in the PHVS excerpt?

The sales were executed by Anne Simonne J. Lesage and Graymatters Consulting B.V. as listed, each with separate trade dates and share quantities under 10b5-1 plans.

What sale sizes are visible in the PHVS excerpt?

Examples include 21,700 shares on 04/30/2026 (gross proceeds $656,550.86) and 8,300 shares on 06/29/2026 (gross proceeds $290,907.83), among other dated transactions.

Do these entries indicate whether proceeds went to the issuer?

No. The excerpt lists gross proceeds per sale but does not state who received the proceeds; cash-flow treatment is not specified in the provided content.

Are these sales described as 10b5-1 transactions or open-market trades?

They are described as 10b5-1 Sales, indicating they were executed pursuant to pre-arranged trading plans as labeled in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973705
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pharvaris N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	310712036410
Name of Person for Whose Account the Securities are To Be Sold	GrayMatters Consulting B.V.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30703	1065701.13	65407822	06/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2016	Founders Shares	Issuer			30703	12/31/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	8300	290907.83
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	6997	245231.56
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80774.46
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80785.59
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	21700	656550.86
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	19200	580909.44
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111280.46
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111229.40
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7500	225361.90
10b5-1 Sales for GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7000	210357.70

144: Remarks and Signature

Remarks
Date of Notice	06/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anne Simone J. Lesage
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)